Literature DB >> 19210708

Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism.

Linda Vignozzi1, Sandra Filippi, Annamaria Morelli, Mirca Marini, Aravinda Chavalmane, Benedetta Fibbi, Enrico Silvestrini, Rosa Mancina, Marco Carini, G Barbara Vannelli, Gianni Forti, Mario Maggi.   

Abstract

BACKGROUND: Most men following radical retropubic prostatectomy (RRP) are afflicted by erectile dysfunction (ED). RRP-related ED occurs as a result of surgically elicited neuropraxia, leading to histological changes in the penis, including collagenization of smooth muscle and endothelial damage. AIM: To verify whether hypogonadism could contribute to the pathogenesis of RRP-ED.
METHODS: Effects of testosterone (T), alone or in association with long-term tadalafil (Tad) treatment in a rat model of bilateral cavernous neurotomy (BCN). MAIN OUTCOME MEASURES: Penile tissues from rats were harvested for vasoreactivity studies 3 months post-BCN. Penile oxygenation was evaluated by hypoxyprobe immunostaining. Phosphodiesterase type 5 (PDE5), endothelial nitric oxide synthase (eNOS), and neuronal nitric oxide synthase (nNOS) mRNA expression were quantified by Real Time quantitative reverse transcription polymerase chain reaction (qRT-PCR).
RESULTS: In BCN rats, we observed the onset of an overt condition of hypogonadism, characterized by reduced T plasma level, reduced ventral prostate weight, reduced testis function (including testis weight and number of Leydig cells), with an inadequate compensatory increase of luteinizing hormone. BCN induced massive penile hypoxia, decreased muscle/fiber ratio, nNOS, eNOS, PDE5 expression, increased sensitivity to the nitric oxide donor, sodium nitroprusside (SNP), and reduced the relaxant response to acetylcholine (Ach), as well as unresponsiveness to acute Tad dosing. In BCN rats, chronic Tad-administration normalizes penile oxygenation, smooth muscle loss, PDE5 expression, SNP sensitivity, and the responsiveness to the acute Tad administration. Chronic Tad treatment was ineffective in counteracting the reduction of nNOS and eNOS expression, along with Ach responsiveness. T supplementation, in combination with Tad, reverted some of the aforementioned alterations, restoring smooth muscle content, eNOS expression, as well as the relaxant response of penile strips to Ach, but not nNOS expression.
CONCLUSION: BCN was associated with hypogonadism, probably of central origin. T supplementation in hypogonadal BCN rats ameliorates some aspects of BCN-induced ED, including collagenization of penile smooth muscle and endothelial dysfunction, except surgically induced altered nNOS expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19210708     DOI: 10.1111/j.1743-6109.2008.01208.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  16 in total

1.  Exercise training improves the defective centrally mediated erectile responses in rats with type I diabetes.

Authors:  Hong Zheng; William G Mayhan; Kaushik P Patel
Journal:  J Sex Med       Date:  2011-08-24       Impact factor: 3.802

2.  Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat.

Authors:  Fara Sirad; Su Hlaing; Istvan Kovanecz; Jorge N Artaza; Leah A Garcia; Jacob Rajfer; Monica G Ferrini
Journal:  J Sex Med       Date:  2011-01-26       Impact factor: 3.802

3.  Valproic acid prevents penile fibrosis and erectile dysfunction in cavernous nerve-injured rats.

Authors:  Johanna L Hannan; Omer Kutlu; Bernard L Stopak; Xiaopu Liu; Fabio Castiglione; Petter Hedlund; Arthur L Burnett; Trinity J Bivalacqua
Journal:  J Sex Med       Date:  2014-03-18       Impact factor: 3.802

Review 4.  Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors.

Authors:  M Gacci; M Carini; M Salvi; A Sebastianelli; L Vignozzi; G Corona; M Maggi; K T McVary; S A Kaplan; M Oelke; S Serni
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

Review 5.  Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction.

Authors:  Carol A Podlasek; John Mulhall; Kelvin Davies; Christopher J Wingard; Johanna L Hannan; Trinity J Bivalacqua; Biljana Musicki; Mohit Khera; Nestor F González-Cadavid; Arthur L Burnett
Journal:  J Sex Med       Date:  2016-08       Impact factor: 3.802

Review 6.  Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH-LUTS.

Authors:  Selim Cellek; Norman E Cameron; Mary A Cotter; Christopher H Fry; Dapo Ilo
Journal:  Nat Rev Urol       Date:  2014-03-11       Impact factor: 14.432

Review 7.  The role of testosterone in erectile dysfunction.

Authors:  Giovanni Corona; Mario Maggi
Journal:  Nat Rev Urol       Date:  2009-12-08       Impact factor: 14.432

8.  Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo.

Authors:  Alan W Shindel; Zhong-Chen Xin; Guiting Lin; Thomas M Fandel; Yun-Ching Huang; Lia Banie; Benjamin N Breyer; Maurice M Garcia; Ching-Shwun Lin; Tom F Lue
Journal:  J Sex Med       Date:  2010-02-05       Impact factor: 3.802

9.  Erectile preservation following radical prostatectomy.

Authors:  Robert Segal; Arthur L Burnett
Journal:  Ther Adv Urol       Date:  2011-02

Review 10.  Erectile dysfunction after radical prostatectomy: prevalence, medical treatments, and psychosocial interventions.

Authors:  Jessica C Emanu; Isabelle K Avildsen; Christian J Nelson
Journal:  Curr Opin Support Palliat Care       Date:  2016-03       Impact factor: 2.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.